FABP5 correlates with poor prognosis and promotes tumor cell growth and metastasis in cervical cancer

Wei Wang,Hong-juan Chu,Yan-chun Liang,Jia-ming Huang,Chun-liang Shang,Hao Tan,Duo Liu,Yun-he Zhao,Tian-yu Liu,Shu-zhong Yao

DOI: https://doi.org/10.1007/s13277-016-5350-1

2016-09-19

Tumor Biology

Abstract:Fatty acid-binding protein 5 (FABP5) was found in our previous study to be a potential biomarker for lymph node metastasis of cervical cancer. However, the roles of FABP5 in cervical cancer remain unclear. In the present study, FABP5 expression was found to be significantly upregulated in cervical cancer tissues, and high FABP5 expression was significantly correlated with lymph node metastasis, lymphovascular space invasion, the International Federation of Gynecology and Obstetrics (FIGO) stage, and tumor size. Moreover, FABP5 was an independent factor for poor prognosis in cervical cancer patients. Silencing of FABP5 inhibited cell proliferation, colony formation, cell migration, and invasion in vitro. Furthermore, FABP5 silencing significantly reduced tumor growth and lung metastases in a murine allograft model in vivo. In addition, FABP5 silencing decreased the expression of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) in vitro and in vivo. Collectively, these findings indicated that FABP5 plays an important role in the carcinogenesis and metastasis of cervical cancer, and FABP5 may be a novel predictor for prognostic assessment of cervical cancer patients.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of fatty - acid - binding protein 5 (FABP5) in the occurrence, development and metastasis of cervical cancer and its prognostic significance. Specifically, the research aims to:

1. **Verify the expression of FABP5 in cervical cancer**: Detect the expression levels of FABP5 in cervical cancer tissues and cell lines by methods such as immunohistochemistry (IHC), real - time quantitative PCR (qPCR) and Western Blot, and compare them with normal cervical tissues.

2. **Explore the role of FABP5 in the proliferation, migration, invasion and metastasis of cervical cancer cells**: Construct a cervical cancer cell line with FABP5 gene silenced (using shRNA technology), observe its effects on cell proliferation, clone - forming ability, migration ability and invasion ability, and further verify its effects on tumor growth and lung metastasis in vivo experiments.

3. **Analyze the relationship between FABP5 and clinicopathological features**: By collecting tissue samples from 206 patients with cervical cancer, analyze the relationship between the expression level of FABP5 and clinicopathological features such as lymph node metastasis (LNM), lymphovascular space invasion (LVSI), FIGO staging and tumor size.

4. **Evaluate the potential of FABP5 as a prognostic marker for cervical cancer**: Through survival analysis, evaluate the relationship between the expression level of FABP5 and the recurrence rate and overall survival rate of patients, and determine whether it can be an independent prognostic factor.

The research results show that the expression of FABP5 in cervical cancer tissues and cell lines is significantly up - regulated, and high expression is closely related to lymph node metastasis, lymphovascular space invasion, FIGO staging and tumor size. In addition, high expression of FABP5 is an independent predictor of poor prognosis in patients with cervical cancer. FABP5 gene silencing can inhibit the proliferation, migration, invasion and metastasis of cervical cancer cells and reduce the expression of MMP - 2 and MMP - 9. These findings suggest that FABP5 may become a potential target for the treatment of cervical cancer.